Clinical outcome of patients colonized and infected by multidrug-resistant bacteria in a private hospital in Fortaleza/Ceará, in 2021
DOI:
https://doi.org/10.33448/rsd-v11i2.26032Keywords:
Antimicrobials; Mortality; Colonization; Bacterium; Infection.Abstract
The COVID-19 pandemic, since 2019, has contributed to aggravating situations that increase the risk of colonization or infection by multidrug-resistant bacteria, such as the indiscriminate use of antimicrobials. The aim of this study was to investigate the relationship between bacterial resistance and negative clinical outcome. A cross-sectional and retrospective study was carried out, where data were collected from the medical records of patients hospitalized in different hospital units (ICU, ward, isolation and neonatology units), from January to December 2021. Inclusion criteria were patients reported with colonization or infection by multidrug-resistant bacteria during hospitalization and with complete data. There were 128 positive samples, with a mean age of 68.2 years. There was a statistically significant difference in mortality when comparing patients younger than 50 years and the age groups between 70-80 years (p=0.006) and above 80 years (p=0.03). Among the three main pathogens isolated and their high mortality rate, there was no statistically significant difference in terms of the overall mortality rate for Acinetobacter baumannii (p = 0.54), Klebsiella pneumoniae (p = 1) and Pseudomonas aeruginosa (p = 1). = 0.82). A statistically significant result was detected for mortality and use of quinolones (p = 0.047) and a trend towards significance for polymyxin (p = 0.09). It was concluded that there was high mortality in patients colonized or infected by multidrug-resistant bacteria in a hospital setting, mainly over 70 years old. The use of quinolones, aminoglycosides and polymyxin seems to be related to higher mortality.
References
ANVISA, Nota Técnica GVIMS/GGTES/ANVISA No 05/2021; Orientações para prevenção e controle da disseminação de microrganismos multirresistentes em serviços de saúde no contexto da pandemia da COVID-19 – 02/08/2021.
Barbier, F., Pommier, C., Essaied, W., Garrouste-Orgeas, M., Schwebel, C., Ruckly, S., Dumenil, A. S., Lemiale, V., Mourvillier, B., Clec'h, C., Darmon, M., Laurent, V., Marcotte, G., Lucet, J. C., Souweine, B., Zahar, J. R., Timsit, J. F., & OUTCOMEREA Study Group (2016). Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure? The Journal of antimicrobial chemotherapy, 71(4), 1088–1097. https://doi.org/10.1093/jac/dkv423
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013). New antibiotics for bad bugs: where are we? Annals of clinical microbiology and antimicrobials, 12, 22. https://doi.org/10.1186/1476-0711-12-22
Bassetti, M., & Righi, E. (2015). New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections. Current opinion in critical care, 21(5), 402–411. https://doi.org/10.1097/MCC.0000000000000235
Bassetti, M., & Righi, E. (2015). Development of novel antibacterial drugs to combat multiple resistant organisms. Langenbeck's archives of surgery, 400(2), 153–165. https://doi.org/10.1007/s00423-015-1280-4
Bertolini, G., Nattino, G., Tascini, C., Poole, D., Viaggi, B., Carrara, G., Rossi, C., Crespi, D., Mondini, M., Langer, M., Rossolini, G. M., & Malacarne, P. GiViTI Steering Committee. (2018). Mortality attributable to different Klebsiella susceptibility patterns and to the coverage of empirical antibiotic therapy: a cohort study on patients admitted to the ICU with infection. Intensive care medicine, 44(10), 1709–1719. https://doi.org/10.1007/s00134-018-5360-0
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clinical infectious Diseases: an official publication of the Infectious Diseases Society of America, 48(1), 1–12. https://doi.org/10.1086/595011
Costa, A. L. P. (2016) Resistência Bacteriana aos Antibióticos: Uma Perspectiva Do Fenômeno Biológico, Suas Consequencias e Estratégias De Contenção. 63 f. Trabalho de Conclusão de Curso (Graduação em Biologia) – Curso de Ciências Biológicas, Departamento de Ciências Biológicas e da Saúde, UNIFAP, Macapá.
Da Silva, H. R., Rocha, A. S. C., Rocha, M. V. S., Veras, D. M., de Sousa, O. M. C., Sousa, G. C., Almeida, D. F., de Oliveira, A. L. P., Bezerra, G. S. S., Ribeiro, D. A. S., Pereira, N. M., Alves, A. K. R., Alves, A. K. R., da Silva, B. B. L., Nogueira, F. D., Rodrigues, S. L. D., & Pessoa, G. T. (2020). Reflection of environmental imbalance in health: multi-resistant bacteria in hospital environment. Research, Society and Development, 9(8), e220985604.
De Carvalho, J. J. V., Boaventura, F. G., da Silva, A. C. R., Ximenes, R. L., Rodrigues, L. K. C., Nunes, D. A. A., & de Souza, V. K. G. (2021). Bactérias multirresistentes e seus impactos na saúde pública: Uma responsabilidade social. Research, Society and Development, 10(6), e58810616303
De Queiroz, G. M., da Silva, L. M., Pietro, R. C. L. R., & Salgado, H. R. N. (2012). Multirresistência microbiana e opções terapêuticas disponíveis / Microbial multi-resistance and available therapeutic options. Rev Bras Clin Med. 10(2), 132-8.
Gabriel, A. C. G., Pinheirp, D. H. P., Fernnades, L. M. S., Wind, M. M., Ferreira, V. R., & Pereira, M. S. (2021). Colonization profile and microbiological resistance in Intensive Care Unit (ICU) patients in the city of Anápolis – GO. Research, Society and Development, 10(16), e588101623853
Gurgel, T. C., & Carvalho, W. S. (2018). A Assistência Farmacêutica e o Aumento da Resistência Bacteriana aos Antibióticos. Latin American Journal of Pharmacy, 27(1), 118-123
Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J. F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021). Timing of antibiotic therapy in the ICU. Critical care (London, England), 25(1), 360. https://doi.org/10.1186/s13054-021-03787-z
Langford, B. J., So M., Raybardhan S., Leung V., Soucy J. R., Westwood D., Daneman N., MacFadden, D. R. (2021). Antibiotic prescribing in patients with COVID- 19: rapid review and meta-analysis. Clinical Microbiology and Infection, 27, 520e531.
Lakbar, I., Medam, S., Ronflé1, R., Cassir, N., Delamarre, L., Hammad, E., Lopez, A., Lepape, A., Machut, A., Boucekine, M., Zieleskiewicz, L., Baumstarck, K., Savey, A., Leone, M. & REA RAISIN Study Group. (2021). Association between mortality and highly antimicrobial‐resistant bacteria in intensive care unit‐acquired pneumonia. Nature Scientific Reports, 11:16497 https://www.nature.com/srep/
Machado, G. M., Lago, A., Fuentefria, S. R. R. & Fuentefria, D. B. (2011). Occurrence and the susceptibility to antimicrobial agents in Pseudomonas aeruginosa and Acinetobacter sp. at a tertiary hospital in southern Brazil. Rev. Soc. Bras. Med. Trop. 44(2), 168-172.
Mota, F. S., Oliveira, H. A., & Souto, R. C. F. (2018). Perfil e prevalência de resistência aos antimicrobianos de bactérias Gram-negativas isoladas de pacientes de uma unidade de terapia intensiva. RBAC. 50(3):270-7. DOI: 10.21877/2448-3877.201800740
Nascimento, C. K. R., Santos, M. M., Oliveira, P. M. C., Iomori, M. V. A. H., Santos, R. M. M., Martins, V. B. D., Melo, B. F., Nascimento, A. L. L., Santos, I. S. P., Dias, T. C., Santos, M. H. S., Rodrigues, A. A., Bezerra, M. S. L., Andrade, R. S. B., & Santos, S. C. (2021). Microbiological and immunological aspects related to the colonization and infection of patients by resistant Acinetobacter baumannii in nosocomial environment. Research, Society and Development, v. 10, n. 2, e25910212650
Queenan, K., Hasler, B. J. & Rushton, A. (2014). One Health approach to antimicrobial resistance surveillance: is there a business case for it? International Journal of Antimicrobial Agents, Volume 48(4).
Ranganathan, P., & Aggarwal, R. (2018). Study designs: Part 1 - An overview and classification. Perspectives in clinical research, 9(4), 184–186. https://doi.org/10.4103/picr.PICR_124_18
Razazi, K., Mekontso Dessap, A., Carteaux, G., Jansen, C., Decousser, J. W., de Prost, N., & Brun-Buisson, C. (2017). Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae. Annals of intensive care, 7(1), 61. https://doi.org/10.1186/s13613-017-0283-4
Santos, I. A. L., Nogueira, J. M. R. & Mendonça, F. C. R. (2015). Mecanismos de resistência antimicrobiana em Pseudomonas aeruginosa. RBAC. 47(1-2), 512.
Souza, E. E. S., Almeida, A. G. C. S., de Souza, C. D. F., Nagliate, P. C., Borges, K. R., & Junges, A. V. (2021). Microbial resistance profile of infections related to health care in a hospital for infectious diseases in a capital of Northeastern Brazil. Research, Society and Development, 10(4), e39910414198.
Vincent, J. L., Sakr, Y., Singer, M., Loeches, I. M., Machado, F. R., Marshall, J. C, Finfer, S. Pelosi, P., Brazzi, L., Aditianingsih, D., Timsit, J. F., Du, B., Wittebole, X., Máca, J., Kannan, S., Delsol, L. A. G., Waele, J. J. D., Mehta, Y., Bonten, M. J. M., Khanna, A. K., Kollef, M., Human, M., & Angus, D. C. (2020). Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA. 323(15):1478–1487. 10.1001/jama.2020.2717. https://jamanetwork.com/journals/jama/fullarticle/2763669
WHO, New report calls for urgent action to avert antimicrobial resistance crisis. 2019. https://www.who.int/news/item/29-04-2019-new-report-calls-for-urgent-action-to-avert-antimicrobial-resistance-crisis
Zeng, L., Yang, C., Zhang, J., Hu, K., Zou, J., Li, J., Wang, J., Huang, W., Yin, L. & Zhang, X. (2021). An Outbreak of Carbapenem- Resistant Klebsiella pneumoniae in an Intensive Care Unit of a Major Teaching Hospital in Chongqing, China. Frontiers in Cellular and Infection Microbiology, June, Volume 11, Article 656070.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Cicero Allan Landim de Oliveira Lima; Ana Lívia Gomes Moreira; Rafael Ferreira Mesquita; Luan Victor Almeida Lima; Bruno Pinheiro Aquino; Melissa Soares Medeiros
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
